Increase text size: A A A

Type in the condition you need,
or visit Advanced Search

Print this page

Email this to a friend

Comment on this page

Save to my Health Library

Johns Hopkins Health Alert

Diabetes and Cataract Surgery

For people with diabetes, cataract surgery poses serious risks, as a recent British study explains.

Surgery for cataracts involves removing all or part of the lens and replacing it with an intraocular lens implant (IOL). Cataract removal is the most frequently performed surgery in people over age 65 and is considered by many doctors to be the most effective surgical procedure in all of medicine. If the eye is normal except for the cataract, surgery will improve vision in more than 95% of cases.

Cataract surgery is remarkably safe. Significant post-surgical complications, such as inflammation, infection, bleeding, swelling, retinal detachment, and glaucoma are rare: They occur in only 1-2% of people. People with other eye diseases and serious medical problems are most at risk for complications.

For example, cataract surgery in diabetics is often followed by complications such as macular edema, retinopathy, and iris neovascularization (abnormal blood vessel growth in the iris). In a recent British study, reported in the British Journal of Ophthalmology (Volume 90, page 697), researchers were able for the first time to correlate such outcomes with a rise in levels of blood vessel growth factors following cataract surgery.

The researchers used fluorescein angiography, an eye test that uses orange dye and a camera to take pictures of the retina, and measured growth factor levels in water-based samples taken from six diabetic patients before cataract surgery and three times following cataract surgery, on days one, seven, and 90.

In four patients, retinopathy in the macula, the center of the retina, worsened. Levels of two factors that promote blood vessel growth -- vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) -- also increased significantly. A different growth factor -- pigment epithelial derived growth factor (PEGF), which discourages new blood vessels from forming -- decreased after cataract surgery. An inflammatory chemical messenger called interleukin 1B also increased, which is normal after cataract surgery but can stimulate the release of VEGF and HGF. The next step, researchers say, is to study whether new anti-VEGF treatments ranibizumab and bevacizumab can control growth factor levels following cataract surgery.

Posted in Vision on May 9, 2008
Reviewed June 2010

Notify Me

Would you like us to inform you when we post new Vision Health Alerts?

Your email address:

Comments

Post a Comment

Health Alerts registered users may post comments and share experiences here at their own discretion. We regret that questions on individual health concerns to the Johns Hopkins editors cannot be answered in this space.

The views expressed here do not constitute medical advice, and do not represent the position of Johns Hopkins Medicine or MediZine LLC, which has no responsibility for any comments posted on this site.




Post a Comment


Already a subscriber?
Login

Email:

Password:


Forgot your password?

New to Johns Hopkins Health Alerts?
Register to submit your comments.

Your Email Address:

(example: yourname@domain.com)

 

(800) 829-0422

Registered Users Log-in:

Email:

Password:

Remember me
Forgot Password?

Become a Registered User!
It's fast and FREE!
The Benefits of Being A Registered User

Health Topic Pages

Arthritis
Back Pain & Osteoporosis
Cancer
Caregivers | Caregiving
Colon Cancer
Complementary Medicine
Depression & Anxiety
Diabetes
Digestive Health
Enlarged Prostate
Exercise and Fitness
Healthy Living
Heart Health
Hypertension & Stroke
Lung Disorders
Memory
Men's Health
Nutrition
Prescription Drugs
Prostate Disorders
Sexual Health
Vision
Weight Control
Women's Health
Health Alert Special Report



Johns Hopkins' Bestsellers

Vision

Our Featured Title:

Johns Hopkins Vision White Paper 2010

  • 2010 Vision White Paper
    Written by Dr. Susan B. Bressler, professor of ophthalmology at the acclaimed Wilmer Eye Institute, and a team of top Johns Hopkins doctors, this comprehensive report is essential reading for anyone affected by a vision disorder, including low vision, cataracts, glaucoma, age-related macular degeneration, and diabetic retinopathy. 88 pages.
    Read more or order the INSTANT PDF DOWNLOAD EDITION
    Read more or order the PRINT EDITION


    Related Titles:

  • 2010 Diabetes White Paper
    The Diabetes White Paper teaches you how to manage Type 1 and Type 2 diabetes and avoid complications, such as nerve damage, heart disease, kidney failure, and retinopathy. This comprehensive report explains the basics of how your body metabolizes glucose and reviews the latest medications and tools for monitoring your blood glucose. Includes diagrams, glossary, and recent research. 96 pages.
    Read more or order the INSTANT PDF DOWNLOAD EDITION
    Read more or order the PRINT EDITION


  • ALL NEW!Number One of America's Best Hospitals 2010-2011: Johns Hopkins

    The Johns Hopkins Hospital has been ranked #1 again in the Honor Roll of America's Best Hospitals by
    U.S. News and World Report for the 20th consecutive year.


    Please visit here for more information about Johns Hopkins Patient Services


    © 2010 MediZine LLC. All rights reserved.
    Contact Us
    customerservice@johnshopkinshealthalerts.com